Mehiläinen account plan
Healthcare services provider
At a glance
Mehiläinen is a Finnish private healthcare and social care group in seven countries with EUR 2,413.2 million of 2025 revenue and over 55,000 staff.
Mehiläinen Group, founded in Helsinki in 1909, is a private provider of healthcare and social care services in Finland, Estonia, Lithuania, Sweden, Germany, Romania and Serbia, trading as Meliva, Regina Maria and MediGroup outside Finland. It serves public sector, corporate and private customers with physician services, hospitals, diagnostics, occupational health, dental care and residential social care, and sells its BeeHealthy digital platform to external customers. In 2025 revenue grew 16.9% to EUR 2,413.2 million (pro forma EUR 3,068.2 million) and underlying EBITA reached EUR 339.4 million; it has 5.2 million customers, 1,450 units and over 55,000 employees and private practitioners. It is owned mainly by funds managed by CVC Capital Partners (41.0%) and Hellman & Friedman (38.1%). In May 2026 it agreed to acquire Aleris, adding Norway and Denmark.
Business units
Healthcare services – North
EUR 1,751.3 million, 72.6% of 2025 revenuePrivate and public healthcare in Finland, Sweden, Estonia, Germany and, from March 2025, Lithuania: medical centres, hospitals, diagnostics, dental, occupational health, freedom-of-choice health centres and outsourcing. 2025 brought new Finnish medical centres and the InMedica acquisition in Lithuania; Anssi Hartiala leads private healthcare and Markku Näreneva public healthcare.
Social care services
EUR 639.4 million, 26.5% of 2025 revenueMostly publicly funded residential care in Finland across about 350 units and more than 8,700 residents: elderly care (Mainiokodit), mental health rehabilitation (Ykköskodit), disability services (Onnikodit) and child welfare (Familar). County savings cut demand in child welfare and mental health; Harri Pomell leads the unit.
Healthcare services – South
EUR 22.5 million, 0.9% of 2025 revenue (consolidated from 18 December 2025)Regina Maria in Romania and MediGroup in Serbia, with combined revenue of circa EUR 550 million in 2024. Regina Maria targets above EUR 1 billion in Romania by 2030; the unit is led by Fady Chreih.
Strategic priorities
- Leading European outpatient provider by 2030
- Mehiläinen aims to become a leading private provider of outpatient healthcare services in Europe by 2030, the most desired employer in its countries and a pioneer in healthcare digitalisation.
- Acquisitive international growth
- Around 200 acquisitions in 10 years; 2025 added InMedica, Regina Maria and MediGroup, and the Aleris deal of May 2026 would take the group to nine European countries and about 60,000 employees.
- Digital healthcare and software
- The OmaMehiläinen app has 2.2 million registered users in Finland, and BeeHealthy sells the platform in more than ten countries and to wellbeing services counties.
- Regina Maria 3.0
- Double the Romanian business by 2030 to above EUR 1 billion, enter new fields and expand into a new country.
- Sustainability targets
- SBTi-approved targets to cut Scope 1-2 emissions by 80% and Scope 3 intensity by 51.6% by 2030 against a 2023 base.
Investments and deals
- Regina Maria and MediGroup
- Romanian and Serbian providers consolidated from 18 December 2025 for consideration of EUR 774.2 million and EUR 100.1 million.
- InMedica (Lithuania)
- Lithuania's largest private healthcare company, acquired from 5 March 2025 and rebranded Meliva; it added EUR 146.2 million revenue in 2025. A new hospital opened in Vilnius and a clinic is under construction in Kaunas.
- Aleris acquisition
- Agreed 18 May 2026, subject to regulatory approval: about 100 clinics and hospitals in Denmark, Norway and Sweden with about 5,300 employees.
- 2025 investment total
- Total investments of EUR 1,125.3 million, of which acquisitions EUR 1,018.5 million and tangible and intangible investments EUR 106.8 million.
- Financing
- EUR 350 million floating-rate and EUR 740 million 5.125% senior secured notes due 2032, plus the repricing of the EUR 1.86 billion term loan.
Challenges and risks
- Public-sector cost cutting in Finland
- Wellbeing services counties cut outsourcing and external staffing, and the Länsi-Pohja Hospital outsourcing ends in 2027.
- High leverage
- Interest-bearing net debt reached EUR 3,436.7 million with gearing of 366.7% and an equity ratio of 17.4%.
- Staff availability
- Availability of professionals is a named risk; employee benefit expenses of EUR 1,129.4 million are the largest cost.
- Fixed-price contracts
- Long-term contracts such as county outsourcing allow only limited price adjustment.
- Internationalisation and currency
- Expansion into new markets brings integration risk and larger foreign-currency exposure in Romania, Serbia and Sweden.
What leadership says
“We've done around 200 acquisitions over the past 10 years”
“We are the one of the most advanced healthcare providers in terms of digital processes”
“More than half of our patients, physician visits, diagnostic tests and surgical procedures are already outside Finland”
Where a supplier can help
- Post-merger integration
- Tied to the acquisitive growth priority: integrating Regina Maria, MediGroup, InMedica and Aleris calls for IT, process and procurement harmonisation at group scale.
- Digital health and AI tools
- Tied to the digital priority: patient app, AI and data tools that extend OmaMehiläinen and BeeHealthy across new countries.
- Healthcare recruitment and workforce tools
- Tied to the staff availability challenge: recruiting, scheduling and retention solutions for a workforce of over 55,000.
- Cost efficiency for public contracts
- Tied to Finnish public-sector cost cutting and fixed-price contracts: tools that lower cost per service help margins on county outsourcing.
- Treasury and currency management
- Tied to the leverage and currency challenges: treasury and FX services for a group with growing exposure outside the euro.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like Mehiläinen?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- Mehiläinen's year 2025 (Business Review, Sustainability Report, Report of the Board of Directors and Financial Statements)
- Mehiläinen Group (parent Mehiläinen Konserni Oy, Helsinki, founded 1909) is a private provider of healthcare and social care services in seven countries: Finland, Estonia, Lithuania, Sweden, Germany, Romania and Serbia; 5.2 million customers, 1,450 units, over 55,000 employees and private practitioners.
- 2025 revenue grew 16.9% to EUR 2,413.2 (2,063.5) million; pro forma revenue including completed acquisitions was EUR 3,068.2 million. Underlying EBITA EUR 339.4 (289.1) million, operating profit EUR 265.3 (231.7) million, profit for the year EUR 88.5 (39.2) million.
- Three segments: Healthcare services – North EUR 1,751.3 million (72.6% of revenue), Social care services EUR 639.4 million (26.5%), Healthcare services – South EUR 22.5 million (0.9%, Regina Maria and MediGroup consolidated from 18 December 2025). Finland is 84.4% (92.6%) of revenue.
- By customer: public sector customers EUR 1,241.4 million, corporate customers EUR 636.7 million, private customers EUR 535.1 million.
- 2025 was a year of international expansion: InMedica (Lithuania's largest private healthcare company, from 5 March 2025), Regina Maria (Romania) and MediGroup (Serbia, both from 18 December 2025). Total investments including acquisitions EUR 1,125.3 (192.3) million; acquisitions alone EUR 1,018.5 million cash.
- Owned by funds managed by CVC Capital Partners (41.0%) and Hellman & Friedman (38.1%, new in 2025), plus Finnish pension investors and management/employees (9.2%). Financed by EUR 350 million floating and EUR 740 million 5.125% senior secured notes due 2032; interest-bearing net debt EUR 3,436.7 million, gearing 366.7%.
- Strategy: become a leading private provider of outpatient healthcare services in Europe by 2030, the most desired employer in its countries and a pioneer in healthcare digitalisation; software arm BeeHealthy sells its platform in more than ten countries.
- Risks named: public-sector cost cutting in Finland (wellbeing services counties cut outsourcing; Länsi-Pohja Hospital outsourcing ends in 2027), fixed-price long-term contracts, staff availability, data protection, internationalisation and a larger foreign-currency exposure (RON, RSD, SEK).
- Outlook 2026: significant growth in revenue and EBITA, driven mainly by the Regina Maria and MediGroup acquisitions; no dividend proposed.
- Mehiläinen acquires Aleris – strengthens its presence in Sweden (press release, Swedish)
- Press release (18 May 2026, Meliva AB, in Swedish): Mehiläinen has signed an agreement to acquire Aleris, subject to regulatory approval.
- Aleris runs about 100 clinics and hospitals in Denmark, Norway and Sweden, about 5,300 employees and over 3.8 million patient visits a year; patients come via public care, health insurance or self-pay.
- The deal strengthens Mehiläinen in Sweden (Meliva since 2020, more than 170,000 listed primary-care patients, about 60 clinics, over 1,000 employees) and adds Norway and Denmark.
- After the deal: about 60,000 employees, over 1,500 units, nine European countries and over 11 million physician visits a year.
- CEO Janne-Olli Järvenpää: combining competences gives patients smoother, more coherent care pathways and helps develop healthcare across the Nordics.
- Logic in Sweden: Aleris's specialist care combined with Meliva's primary care.
- Mehiläinen: A Nordic healthcare success story powered by innovation and partnership (Nordea)
- Nordea corporate-insights piece (27 February 2026) with CEO Janne-Olli Järvenpää on Mehiläinen's growth and financing.
- Revenue grew more than fivefold over the past decade, surpassing EUR 2 billion in 2024; 2.2 million customers a year across 890 locations, over 37,000 employees and private practitioners (Finland figures given in the piece).
- Digital as growth driver: "We are the one of the most advanced healthcare providers in terms of digital processes"; patient app used by 2 million registered patients in Finland; BeeHealthy sells the platform to 10 countries.
- Acquisitions: "We've done around 200 acquisitions over the past 10 years", making Mehiläinen a European player in seven countries.
- Financing: Nordea supported the EUR 1.09 billion bond issue and the repricing of the EUR 1.86 billion term loan that funded Romania and Serbia.
- Ambition: become a leading European outpatient-focused healthcare provider; "More than half of our patients, physician visits, diagnostic tests and surgical procedures are already outside Finland".
- Rețeaua de Sănătate REGINA MARIA: Medicina viitorului în slujba oamenilor (Revista Biz)
- Interview (Romanian, Revista Biz, 21 October 2025) with Fady Chreih, CEO of Regina Maria, now Mehiläinen's Managing Director, Healthcare South, on Regina Maria's 30 years and next steps.
- Scale (translated): 7 million patient visits a year, over 13,000 corporate partners, 1 million subscriptions, over 400 own and partner locations, 6 hospitals, 36 laboratories, 3 IVF centres, 18 dental clinics.
- With MediGroup in Serbia (over 100 locations), 13,600 employees and collaborators across Romania and Serbia.
- Nearly EUR 300 million invested so far in hospitals, clinics and laboratories; patient feedback system with one million reviews averaging 9.63.
- Target "REGINA MARIA 3.0": double the business in Romania by 2030, above EUR 1 billion in Romania alone, enter new fields and markets and expand into a new country.
- Positions the medical subscription as a key prevention tool and claims the most international accreditations for centres of excellence in Europe.
- Calls the Mehiläinen deal the transaction of the year in Central and Eastern European healthcare (then awaiting competition approval).
Questions about Mehiläinen
What does Mehiläinen do?
Mehiläinen is a private provider of healthcare and social care services, running medical centres, hospitals, diagnostics, occupational health, dental care and residential care in seven countries.
What is Mehiläinen's revenue?
Revenue was EUR 2,413.2 million in 2025, up 16.9%; pro forma revenue including completed acquisitions was EUR 3,068.2 million.
How many employees does Mehiläinen have?
It has over 55,000 employees and private practitioners; the Aleris deal would bring the group to about 60,000 employees.
Who owns and leads Mehiläinen?
Funds managed by CVC Capital Partners (41.0%) and Hellman & Friedman (38.1%) are the main owners. Janne-Olli Järvenpää is CEO and Andreas Tallberg chairs the board.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)